Here's Why Maximus Stock Is a Great Pick for Your Portfolio
Werte in diesem Artikel
Maximus MMS, a leading global provider of government health and human-services programs, has performed well over the year-to-date period and has the potential to sustain momentum in the near term. If you have not yet taken advantage of the share price appreciation, you should consider adding the stock to your portfolio now. What Makes MMS an Attractive Pick?An Outperformer: A glimpse at the company’s price trend shows that the stock has had an impressive run over the year-to-date period. Shares of MMS have rallied 17.5% in the same time period, outperforming the 5% decline of the Government Services industry it belongs to. Image Source: Zacks Investment ResearchSolid Rank: MMS sports a Zacks Rank #1 (Strong Buy).Positive Earnings Surprise History: MMS has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed once, delivering an earnings surprise of 29.3%, on average. Strong Growth Prospects: The Zacks Consensus Estimate for Maximus’s 2025 revenues is pegged at $5.45 billion, reflecting 2.74% year-over-year growth. The consensus estimate for 2025 earnings is pegged at $7.41, hinting at a 21.28% year-over-year increase.Growth Factors: Maximus is enhancing its competitive edge with the achievement of CMMC Level 2 certification in August 2025. This demonstrates its ability to meet strict Department of Defense cybersecurity standards, safeguard sensitive defense data and accelerate program launches by bypassing lengthy Authorization to Operate delays. This milestone reinforces Maximus’ position as a trusted partner for defense and national security missions.MMS's current ratio (a measure of liquidity) at the end of the third quarter of fiscal 2025 was 2.27, higher than the industry’s 1.35. A current ratio of more than 1 indicates that the company should not have problems meeting its short-term obligations.Moreover, the company has a solid track record of dividend payments. During fiscal 2021, 2022, 2023 and 2024, Maximus paid cash dividends of $68.8 million, $68.7 million, $68 million and $72.9 million, respectively. These steady payouts indicate the company’s commitment to creating value for shareholders and highlight its confidence in the business.Other Stocks to ConsiderSome other top-ranked stocks to consider from the broader Zacks Business Services sector are Green Dot (GDOT) and AppLovin (APP) Green Dot sports a Zacks Rank of #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks hereGDOT has an encouraging earnings surprise history, having outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missing once. The average beat is 42.1%.AppLovin also sports a Zacks Rank of 1.APP has an encouraging earnings surprise history, topping the Zacks Consensus Estimate in each of the trailing four quarters. The average beat is 22.36%.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Green Dot Corporation (GDOT): Free Stock Analysis Report Maximus, Inc. (MMS): Free Stock Analysis Report AppLovin Corporation (APP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Maximus und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Maximus
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Maximus
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Maximus Inc.
Analysen zu Maximus Inc.
Datum | Rating | Analyst | |
---|---|---|---|
08.05.2018 | Maximus Overweight | First Analysis Securities | |
08.02.2018 | Maximus Hold | Maxim Group | |
04.05.2017 | Maximus Hold | Maxim Group | |
07.04.2017 | Maximus Hold | Canaccord Adams | |
04.12.2015 | Maximus Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
08.05.2018 | Maximus Overweight | First Analysis Securities | |
04.12.2015 | Maximus Buy | Stifel, Nicolaus & Co., Inc. | |
12.11.2015 | Maximus Buy | Maxim Group | |
06.08.2015 | Maximus Buy | Maxim Group | |
07.05.2015 | Maximus Buy | Maxim Group |
Datum | Rating | Analyst | |
---|---|---|---|
08.02.2018 | Maximus Hold | Maxim Group | |
04.05.2017 | Maximus Hold | Maxim Group | |
07.04.2017 | Maximus Hold | Canaccord Adams | |
24.08.2006 | Update Maximus Inc.: Hold | Matrix Research | |
15.07.2005 | Update Maximus Inc.: Neutral | Sun Trust Robinson Humphrey |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Maximus Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen